Valuation: BioElectronics Corporation

Market Cap 1.24Cr 1.08Cr 99.63L 91.58L 1.74Cr 118.86Cr 1.76Cr 12Cr 4.67Cr 58Cr 4.64Cr 4.54Cr 200.24Cr P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 2.57Cr 2.25Cr 2.07Cr 1.9Cr 3.61Cr 247.23Cr 3.67Cr 25Cr 9.71Cr 120.84Cr 9.65Cr 9.44Cr 416.51Cr EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 month-25.00%
3 months-25.00%
6 months-25.00%
Current year-25.00%
1 week 0
Extreme 0.000265
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 15/11/2019
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 15/11/2019
Chairman 85 15/06/2020
Director/Board Member - 03/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+50.00%-40.00% 74.12L
+0.87%+5.30%+28.51%+2.27% 20TCr
+2.96%-6.08%-23.89%+10.18% 13TCr
+1.23%+5.44%+4.30%-15.40% 14TCr
+1.74%-3.46%-58.19%-17.77% 6.34TCr
-2.24%-5.92%+14.69%-4.92% 5.19TCr
+1.34%+1.46%-24.75%-32.52% 4.38TCr
+0.07%+4.22%+19.11%+13.76% 3.82TCr
+0.47%+2.44%+30.24%+39.76% 3.7TCr
+2.84%-1.89%-14.69%-21.84% 2.8TCr
Average +0.93%-2.17%+2.53%-6.65% 7.36TCr
Weighted average by Cap. +1.22%-2.03%+0.65%-2.41%

Financials

2020 2021
Net sales 8L 7L 7L 6L 11.65L 7.98Cr 11.85L 79.88L 31.34L 3.9Cr 31.15L 30.47L 13Cr 16.09L 14.07L 12.98L 11.93L 22.61L 15Cr 23L 1.55Cr 60.81L 7.57Cr 60.44L 59.12L 26Cr
Net income -11.6L -10.14L -9L -9L -16.29L -11Cr -16.57L -1.12Cr -43.81L -5.45Cr -43.55L -42.6L -19Cr -3L -3L -2L -2L -4L -2.79Cr -4L -27.91L -10.95L -1.36Cr -10.88L -10.65L -4.7Cr
Net Debt 1.31Cr 1.14Cr 1.05Cr 96.88L 1.84Cr 125.74Cr 1.87Cr 13Cr 4.94Cr 61Cr 4.91Cr 4.8Cr 211.83Cr 1.33Cr 1.17Cr 1.08Cr 98.92L 1.87Cr 128.38Cr 1.91Cr 13Cr 5.04Cr 63Cr 5.01Cr 4.9Cr 216.27Cr
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
15/26/15 $0.000300 0.00% 1,29,25,000
14/26/14 $0.000300 -14.29% 1,62,32,194
13/26/13 $0.000350 0.00% 6,09,150
10/26/10 $0.000350 +16.67% 71,75,850
09/26/09 $0.000300 0.00% 17,60,525
  1. Stock Market
  2. Stocks
  3. BIEL Stock